Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.860
+0.030 (1.64%)
At close: Sep 4, 2026, 4:00 PM EDT
1.830
-0.030 (-1.61%)
After-hours: Sep 4, 2026, 4:10 PM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $5.5 million as of September 4, 2026. Its market cap has decreased by -19.74% in one year.
Market Cap
5.50M
Enterprise Value
287.61K
1-Year Change
-19.74%
Ranking
Category
Stock Price
$1.86
ChartMarket Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $5.50M, a decrease of -98.51%. That is a compound annual growth rate of -64.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 5.50M | 11.24% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.18M |
| NuCana | 6.16M |
| Processa Pharmaceuticals | 5.73M |
| Can-Fite BioPharma | 5.73M |
| Kairos Pharma | 5.65M |
| PharmaCyte Biotech | 5.27M |
| HCW Biologics | 5.27M |
| GRI Bio | 5.01M |